Cargando…

Interstitial Lung Disease after Pleurodesis for Malignant Pleural Effusion

OBJECTIVE: Pleurodesis is an effective therapy for malignant pleural effusion (MPE). While interstitial lung disease (ILD) has been regarded as a serious complication of pleurodesis, its clinicopathological characteristics have not been fully understood. This study was conducted to elucidate the inc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yokoe, Norihito, Katsuda, Eisuke, Kosaka, Kenshi, Hamanaka, Rie, Matsubara, Ayako, Nishimura, Masaki, Tanaka, Hiroyuki, Asai, Nobuhiro, Takahashi, Ayumu, Kawamura, Toshiki, Ishiguchi, Tsuneo, Yamaguchi, Etsuro, Kubo, Akihito
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Japanese Society of Internal Medicine 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5548670/ https://www.ncbi.nlm.nih.gov/pubmed/28717073 http://dx.doi.org/10.2169/internalmedicine.56.7464

Ejemplares similares

Chylothorax and Bilious Pleural Effusion
por: Yokoe, Norihito, et al.
Publicado: (2019)

A case of autoimmune pulmonary alveolar proteinosis with fluctuating lung shadows in parallel with cigarette smoke burden
por: Takahashi, Ayumu, et al.
Publicado: (2017)

Bicytopenia in Primary Lung Melanoma Treated with Nivolumab
por: Takahashi, Ayumu, et al.
Publicado: (2018)

Povidone-iodine pleurodesis versus talc pleurodesis in preventing recurrence of malignant pleural effusion
por: Ibrahim, Islam M, et al.
Publicado: (2015)

Still’s disease with pleural effusion submitted to a pleurodesis
por: Carvalho, Jozélio, et al.
Publicado: (2021)

Ambulatory Thoracoscopic Pleurodesis Combined With Indwelling Pleural Catheter in Malignant Pleural Effusion
por: Foo, Chuan T., et al.
Publicado: (2021)

Efficacy and Safety of Povidone-iodine Pleurodesis in Malignant Pleural Effusions
por: Kahrom, Hadi, et al.
Publicado: (2017)

Adverse events after pleurodesis in patients with malignant pleural effusion
por: Terra, Ricardo Mingarini, et al.
Publicado: (2020)

Pleural Space Elastance and Its Relation to Success Rates of Pleurodesis in Malignant Pleural Effusion
por: Masoud, Hossam Hosny, et al.
Publicado: (2021)

Mitoxantrone pleurodesis to palliate malignant pleural effusion secondary to ovarian cancer
por: Barbetakis, Nikolaos, et al.
Publicado: (2004)

Successful pleurodesis with OK-432 in preterm infants with persistent pleural effusion
por: Kim, Jeong Eun, et al.
Publicado: (2012)

The Inflammatory Cytokine Profile of Patients with Malignant Pleural Effusion Treated with Pleurodesis
por: Hsu, Li-Han, et al.
Publicado: (2020)

Results of chemical pleurodesis with mitoxantrone in malignant pleural effusion from breast cancer
por: Barbetakis, Nikolaos, et al.
Publicado: (2004)

Long-term results of pleurodesis in malignant pleural effusions: Doxycycline vs Bleomycin
por: Rafiei, Rahmatollah, et al.
Publicado: (2014)

Efficacy and Safety of Talc Pleurodesis for Malignant Pleural Effusion: A Meta-Analysis
por: Xia, Huan, et al.
Publicado: (2014)

Survival and pleurodesis outcome in patients with malignant pleural effusion – a systematic review
por: Hassan, Maged, et al.
Publicado: (2021)

Multimodal approach to the management of malignant pleural effusions: role of thoracoscopy with pleurodesis and tunneled indwelling pleural catheters
por: Agrawal, Abhinav, et al.
Publicado: (2020)

Does attempting talc pleurodesis affect subsequent indwelling pleural catheter (IPC)-related non-draining septated pleural effusion and IPC-related spontaneous pleurodesis?
por: Asciak, Rachelle, et al.
Publicado: (2019)

A novel approach for preventing recurrence of malign pleural effusion: early phase pleurodesis
por: Cobanoglu, Ufuk, et al.
Publicado: (2018)

Pleurodesis with povidone iodine in patients with malignant pleural effusion in a tertiary center in Nigeria
por: Omoregbee, Benjamin Irene, et al.
Publicado: (2021)

Effectiveness and safety of outpatient pleurodesis in patients with recurrent malignant pleural effusion and low performance status
por: Terra, Ricardo Mingarini, et al.
Publicado: (2011)

Silver nitrate versus tetracycline in pleurodesis for malignant pleural effusions; a prospective randomized trial
por: Tabatabaei, Seyed Abass, et al.
Publicado: (2015)

Ultrasound-guided intrapleural positioning of pleural catheters: influence on immediate lung expansion and pleurodesis in patients with recurrent malignant pleural effusion
por: de Araujo, Pedro Henrique Xavier Nabuco, et al.
Publicado: (2017)

Video-assisted thoracoscopic iodopovidone pleurodesis for malignant pleural effusions in moderate to high-risk Colombian patients
por: Garzón, Juan Carlos, et al.
Publicado: (2020)

Talc pleurodesis versus indwelling pleural catheter among patients with malignant pleural effusion: a meta-analysis of randomized controlled trials
por: Wang, Li, et al.
Publicado: (2020)

Efficacy of sonographic and biological pleurodesis indicators of malignant pleural effusion (SIMPLE): protocol of a randomised controlled trial
por: Psallidas, Ioannis, et al.
Publicado: (2017)

Predictors of survival in patients who underwent video‐assisted thoracic surgery talc pleurodesis for malignant pleural effusion
por: Yoon, Dong Woog, et al.
Publicado: (2016)

Protocol of the Australasian Malignant Pleural Effusion (AMPLE) trial: a multicentre randomised study comparing indwelling pleural catheter versus talc pleurodesis
por: Fysh, Edward T H, et al.
Publicado: (2014)

Release of growth factors after mechanical and chemical pleurodesis for treatment of malignant pleural effusion: a randomized control study
por: Hojski, Aljaz, et al.
Publicado: (2015)

Efficacy and safety profile of autologous blood versus talc pleurodesis for malignant pleural effusion: a randomized controlled trial
por: Keeratichananont, Warangkana, et al.
Publicado: (2018)

Chemical pleurodesis using mistletoe extracts via spray catheter during medical thoracoscopy for management of malignant pleural effusion
por: Eom, Jung Seop, et al.
Publicado: (2017)

Influence of the progression of pleural neoplasia on the outcome of pleurodesis in mice
por: Sabbion, Rodrigo Olivio, et al.
Publicado: (2020)

Effect of percutaneous radiofrequency ablation after thoracoscopic pleurodesis for treating non‐small cell lung cancer patients with malignant pleural effusion and/or pleural dissemination
por: Liu, Baodong, et al.
Publicado: (2016)

Australasian Malignant PLeural Effusion (AMPLE)-3 trial: study protocol for a multi-centre randomised study comparing indwelling pleural catheter (±talc pleurodesis) versus video-assisted thoracoscopic surgery for management of malignant pleural effusion
por: Fitzgerald, Deirdre B., et al.
Publicado: (2022)

Pre-EDIT: protocol for a randomised feasibility trial of elastance-directed intrapleural catheter or talc pleurodesis (EDIT) in malignant pleural effusion
por: Martin, Geoffrey A, et al.
Publicado: (2018)

Successful Crizotinib Rechallenge after Crizotinib-Induced Organizing Pneumonia in Anaplastic Lymphoma Kinase-Rearranged Non-Small Cell Lung Cancer
por: Asai, Nobuhiro, et al.
Publicado: (2014)

TLR2 in Pleural Fluid Is Modulated by Talc Particles during Pleurodesis
por: Jankovicova, Karolina, et al.
Publicado: (2012)

Chemical pleurodesis – a review of mechanisms involved in pleural space obliteration
por: Mierzejewski, Michal, et al.
Publicado: (2019)

Risk factors related to pleural empyema after talc slurry pleurodesis
por: D'Ambrosio, Paula Duarte, et al.
Publicado: (2022)

Can EGFR-Tyrosine Kinase Inhibitors (TKI) Alone Without Talc Pleurodesis Prevent Recurrence of Malignant Pleural Effusion (MPE) in Lung Adenocarcinoma
por: Verma, Akash, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_d5ech9cjoi0go50bua0i40c9e7